scholarly journals Evaluation of Neo-Osteogenesis in Eosinophilic Chronic Rhinosinusitis Using a Nasal Polyp Murine Model

2020 ◽  
Vol 12 (2) ◽  
pp. 306
Author(s):  
Roza Khalmuratova ◽  
Mingyu Lee ◽  
Jong-Wan Park ◽  
Hyun-Woo Shin
2014 ◽  
Vol 124 (9) ◽  
Author(s):  
Mikio Hirotsu ◽  
Akihito Shiozawa ◽  
Noritsugu Ono ◽  
Masato Miwa ◽  
Ken Kikuchi ◽  
...  

Allergy ◽  
2020 ◽  
Author(s):  
Ryoji Kagoya ◽  
Kenji Kondo ◽  
Megumi Kishimoto‐Urata ◽  
Yuya Shimizu ◽  
Shu Kikuta ◽  
...  

2019 ◽  
Vol 33 (4) ◽  
pp. 378-387 ◽  
Author(s):  
Yoshiyuki Nagata ◽  
Shuichiro Maruoka ◽  
Yasuhiro Gon ◽  
Kenji Mizumura ◽  
Hiroyuki Kishi ◽  
...  

Background Nasal polyps accompany eosinophilic chronic rhinosinusitis (ECRS). Cytokines, including interleukin (IL)-25, IL-33, and thymic stromal lymphopoietin (TSLP) expressed in nasal mucosa have been implicated in polyp pathogenesis. We investigated the role of nasal polyp epithelium cytokine expression in eosinophilic infiltration in ECRS. Methods Tissues were collected from 39 patients undergoing nasal surgery. Cases were divided into 3 groups: control (CTR), non-ECRS (nECRS), and ECRS and were evaluated for IL-25, IL-33, and TSLP expression. Results Abundant eosinophilia was observed underneath the nasal mucosa and around the nasal ducts in polyps in ECRS and correlated positively with IL-33 protein expression. Conclusion Cytokine expression in nasal duct cells and eosinophilic infiltration around duct cells similar to those in the nasal mucosa occurred in the nasal epithelium of polyps, suggesting its role in inducing eosinophilic inflammation.


2019 ◽  
Vol 133 (22) ◽  
pp. 2301-2315 ◽  
Author(s):  
Xia Li ◽  
Zhiyuan Wang ◽  
Lihong Chang ◽  
Xiaohong Chen ◽  
Luoying Yang ◽  
...  

Abstract Eosinophilic chronic rhinosinusitis with nasal polyps (ECRS) is a condition linked with type 2 inflammation, poor treatment outcomes, and high recurrence tendency. Although γδT cells have been reported to induce type 2 immune responses and eosinophilic infiltration in several diseases, their role in ECRS has not been fully explored. We aimed to evaluate the association of γδT cells with the type 2 inflammatory profiles in ECRS. Nasal tissue samples obtained from patients with chronic rhinosinusitis with nasal polyps (CRSwNP) (51 eosinophilic and 48 non-eosinophilic), 50 patients with chronic rhinosinusitis without nasal polyps (CRSsNP), and 58 control subjects were examined for γδT cells, inflammatory markers and eosinophils using HE, RT-qPCR, ELISA, immunofluorescence, and flow cytometry. In parallel, studies were also conducted in an ECRS murine model induced by anti-γδT cells neutralizing antibody administration. γδT cells expression was significantly increased in tissues from patients with ECRS compared with non-ECRS, CRSsNP and control subjects. Moreover, inflammatory markers including type 2 proinflammatory cytokines (IL-4, IL-5, IL-13), GATA3, eosinophil cationic protein (ECP), and eotaxin levels were also increased in nasal tissues of patients with ECRS, and Vγ1+ γδT cells mRNA expression was positively correlated with type 2 cytokines, GATA3, and ECP. In the ECRS murine model, anti-Vγ1+ γδT antibody treatment reduced the infiltration of eosinophils and expression of type 2 cytokines, GATA3, and ECP in nasal mucosae. In conclusion, the results of the present study suggest that γδT cells play a crucial role in the type 2 inflammatory profiles and nasal tissue eosinophilic infiltration in patients with ECRS.


2019 ◽  
Vol 276 (8) ◽  
pp. 2273-2282 ◽  
Author(s):  
Sang Chul Park ◽  
Soo In Kim ◽  
Chi Sang Hwang ◽  
Hyung-Ju Cho ◽  
Joo-Heon Yoon ◽  
...  

2020 ◽  
pp. 194589242096440
Author(s):  
Hyun Jin Min ◽  
Kyung Soo Kim

Background Eosinophilic chronic rhinosinusitis with nasal polyps (ECRSwNP) is histologically distinct from non-eosinophilic CRSwNP (NECRSwNP) and exhibits a high frequency of recurrence. The differences between the pathogenesis of ECRSwNP and NECRSwNP are not well-characterized. HMGB1 has been implicated in the pathogenesis of CRSwNPs; however, its precise contributions to ECRSwNP and NECRSwNP have not been established. Objective We evaluated the role of HMGB1 in the pathogenesis of ECRSwNP. Methods A total of 26 nasal polyps (NPs) from patients with ECRSwNP and NECRSwNP who underwent endoscopic sinus surgery were obtained. Western blotting and immunohistochemistry were performed to compare the HMGB1 levels between the NPs from ECRS and NECRS. A multiplex cytokine assay was performed to evaluate the levels of other cytokines and chemokines in exudates in the NPs. Nasal lavage fluids were used to evaluate extracellular HMGB1 levels using enzyme-linked immunosorbent assay. Results HMGB1 expression in the NPs was higher in ECRSwNP than in NECRSwNP. The level of HMGB1 in the exudate within the NPs was significantly higher in ECRSwNP than in NECRSwNP. Furthermore, HMGB1 levels in nasal lavage fluids from ECRSwNP were higher than those from NECRSwNP. We found that HMGB1 levels in the exudate in NPs and in nasal lavage fluids effectively differentiate ECRSwNP from NECRSwNP. Conclusion Our results suggest that a high level of HMGB1 in NPs is an important factor for differentiating ECRSwNP from NECRSwNP. HMGB1 may play a role in the development of ECRSwNP and should be further evaluated.


2002 ◽  
Vol 127 (6) ◽  
pp. 512-515 ◽  
Author(s):  
Pablo Arango ◽  
Larry Borish ◽  
Henry F. Frierson ◽  
Stilianos E. Kountakis

OBJECTIVES: Our study was designed to demonstrate that, similar to asthma, eosinophilic chronic rhinosinusitis is a disease characterized by activation and the expression of cysteinyl leukotrienes (LTs). METHODS: Nasal polyp tissue was evaluated from 28 consecutive individuals undergoing elective polypectomy in whom neutrophils were not present on pathologic examination. Tissue was analyzed for pathosis with particular attention to the presence of eosinophils. Patients with moderate to high levels of mucosal eosinophils were classified as having eosinophilic rhinosinusitis (ECRS). Those with few or absent mucosal eosinophils were classified as having noneosinophilic rhinosinusitis (NECRS). Cysteinyl LTs were quantified by a sensitive competitive enzyme immunoassay, and the levels of cysteinyl LTs were compared in the groups. RESULTS: There were 20 patients with ECRS and 8 patients with NECRS. Cysteinyl LTs were identified in polyp tissue from 24 of 28 subjects and were >5 pg/gm tissue in 15 of 28. The average level of LTC4 in patients with few mucosal eosinophils was 38.3 pg/g. The average amount in those with moderate to large amounts of mucosal eosinophils was 36.7 pg/g. There was no significant difference between the 2 groups. CONCLUSION: ECRS and NECRS can be considered diseases of excessive expression of cysteinyl LTs. LT expression occurs in patients who demonstrate few or no mucosal eosinophils, which indicates that cell lines other than eosinophils may be responsible for LT production in chronic rhinosinusitis.


Sign in / Sign up

Export Citation Format

Share Document